Brief: PYC Therapeutics Says U.S. FDA Grants Rare Pediatric Disease Designation To VP-001
20/01/2025 24:06
Jan 20 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* U.S. FDA GRANTS RARE PEDIATRIC DISEASE DESIGNATION TO
VP-001
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director